Spinosin has been reported to alleviate cognitive impairment by improving the neurotrophic factor (BDNF) and Bcl-2, decreasing the level of MDA, and inhibiting the inflammatory factor IL-6 in the brain (Xu et al., 2019). This evidence concerns the gene BDNF and Cognitive impairment.